MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    “Step-by-Step” in Movement Disorders: A Disease-Specific, Multi-Method Integrated Teaching Approach

    W. Wang, D. Dong, W. Wu, C. Cen, L. Luo (Hangzhou, China)

    Objective: To evaluate the effectiveness of a novel “Step-by-Step” teaching round model in improving neurology residents’ knowledge and clinical competency in movement disorders. Background: Movement…
  • 2026 International Congress

    Phenotypic and Genotypic Spectrum of MAPT-associated Parkinsonism in a Multi-ethnic Malaysian Cohort

    JP. Schee, YW. Tay, TS. Toh, AN. Khairul Anuar, HX. Ding, JWY. Tee, AL. Lee, A. Ahmad-Annuar, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: To describe the phenotypic continuum and genotypic spectrum of microtubule-associated protein tau (MAPT)-associated parkinsonism in a multi-ethnic Malaysian cohort. Background: Carriers of pathogenic MAPT…
  • 2026 International Congress

    Urine-derived neuronal extracellular vesicle α-synuclein seed amplification assay for synucleinopathies: a non-invasive biomarker study

    HBT. Tran, TA. Nguyen, HJ. Choi, HD. Nguyen, IH. Kwak, DG. Ko, JK. Yu, SJ. Song, JH. Lim, YE. Kim (Chuncheon, Republic of Korea)

    Objective: To investigate whether pathogenic α-synuclein can be detected using real-time quaking-induced conversion (RT-QuIC) in urine-derived neuronal extracellular vesicles (NEVs) as a fully non-invasive biomarker…
  • 2026 International Congress

    Brain-Derived Neurotrophic Factor as a Biomarker of Depression in Parkinson’s Disease

    IH. Kwak, YE. Kim, HI. Ma, JK. Yu, DG. Ko, JJ. Lee, HD. Nguyen, HBT. Tran, HJ. Choi, SJ. Song (Anyang, Republic of Korea)

    Objective: ​​​​​​To determine whether peripheral neurodegeneration-related biomarker levels differ between patients with Parkinson’s disease (PD) with and without depression and to identify biomarkers associated with…
  • 2026 International Congress

    Clinical and Functional Outcomes of Antiviral and Immunomodulatory Therapies in Subacute Sclerosing Panencephalitis

    S. Errabelly, V. Jadhav, M. Tripathi, D. Dash, P. Mohapatra, E. Arunmozhimaran (New Delhi, India)

    Objective: To evaluate whether antiviral and immunomodulatory treatments meaningfully improve true functional status and disease stabilization, or if they merely prolong survival in a state…
  • 2026 International Congress

    Botulinum toxin treatment patterns and outcomes in head and neck dystonia: experience from a tertiary, multidisciplinary clinical service

    R. Everitt, R. Aggarwal, R. Mcdonagh, C. Kobylecki (Salford, United Kingdom)

    Objective: To evaluate outcomes following Botulinum toxin (BoNT) treatment for head and neck dystonia in a tertiary multidisciplinary clinic, characterise adverse effects and identify treatment…
  • 2026 International Congress

    Immunological principles of levodopa therapy in Parkinson’s disease

    N. Naimov, B. Muminov, S. Jumanazarova, R. Matmurodov, H. Daminova (Tashkent, Uzbekistan)

    Objective: Study of the relationship between serum IL-10 levels in patients with Parkinson's disease and levodopa therapy Background: In Parkinson's disease, dehydroepiandrosterone can lead to…
  • 2026 International Congress

    Spectrum of Orthopaedic Problems in Patients with Movement Disorders: A Systematic Review of Clinical Manifestations

    U C. Saini (Chandigarh, India)

    Objective: To identify and summarizes the spectrum of orthopedic problems reported in patients with movement disorders Background: Movement disorders such as Parkinson's disease, Dystonia, Essential tremor,…
  • 2026 International Congress

    Interleukin 6 in the assessment of Parkinson’s disease and Progressive Supranuclear Palsy

    N. Madetko-Alster, M. Markiewicz, P. Chunowski, P. Alster (Warsaw, Poland)

    Objective: The aim of this research is to analyze the relevance of serum interleukin 6 levels in the evaluation of Parkinson’s disease (PD) and Progressive…
  • 2026 International Congress

    Point-of-Care Neuromuscular Ultrasound With Fractal Biomarkers for Stratification of Neuropathic and Myogenic Drivers of Motor Decline

    R. Bubnov, L. Kalika, Z. Pilecki (Kyiv, Ukraine)

    Objective: We investigated whether a structured ultrasound protocol integrating fascicular morphometry, fractal image analysis, and AI-assisted classification can stratify neuropathic versus myogenic contributors to motor…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley